Clinical Trials Directory

Trials / Terminated

TerminatedNCT02207582

Prefrontal Transcranial Random Noise Stimulation in Patients With Depression

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
University of Regensburg · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Transcranial random noise stimulation is used to stimulate the prefrontal cortices in patients with depression. It's a placebo-controlled two-arm study.

Detailed description

Transcranial random noise stimulation (tRNS) is a non-invasive electric stimulation technique of the brain which was shown to be superior effective in contrast to other electric stimulation such as transcranial direct current stimulation (tDCS). These studies investigated mainly healthy controls and specific tasks. Only one case report is available for depression. Here we stimulate patients with depression with tRNS in a placebo-controlled two-arm design. Stimulation will be done as add-on to standard therapy. Electrodes will be applied over both dorsolateral prefrontal cortices which are standard target points of tDCS and also transcranial magnetic stimulation in depression.

Conditions

Interventions

TypeNameDescription
DEVICEVerum Prefrontal tRNS2mA of tRNS (DC-Stimulator, NeuroConn GmbH, Germany) with a zero offset will be applied to the left and right dorsolateral prefrontal cortex. Treatment will consist of 15 days with 20 minutes stimulation per day. Voltage will be ramped at the begin and end of a stimulation for 10 seconds.
DEVICEPlacebo Prefrontal tRNS2mA of tRNS (DC-Stimulator, NeuroConn GmbH, Germany) with a zero offset will be applied to the left and right dorsolateral prefrontal cortex. Treatment will consist of 15 days with 20 minutes stimulation per day. Voltage will be ramped at the begin and end of a stimulation for 10 seconds. Placebo stimulation will consist of just applying the ramps at the begin and end of the stimulation.

Timeline

Start date
2014-07-01
Primary completion
2016-10-14
Completion
2016-12-06
First posted
2014-08-04
Last updated
2018-06-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02207582. Inclusion in this directory is not an endorsement.